Part D and dually eligible patients with mental illness: Medication access problems and use of intensive services

Psychiatric Services

Volumn 60, Issue 9, 2009, Pages 1169-1174

  Huskamp, Haiden A ^a   West, Joyce C ^b   Rae, Donald S ^b   Rubio Stipec, Maritza ^b   Regier, Darrel A ^b   Frank, Richard G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b AMERICAN PSYCHIATRIC ASSOCIATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; FEMALE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE QUALITY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAID; MEDICARE; MENTAL DISEASE; MENTAL HEALTH SERVICE; PATIENT CARE; PSYCHIATRIC DEPARTMENT; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; SUBSTANCE ABUSE;

EID: 69949085850     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/ps.2009.60.9.1169     Document Type: Article

References (24)

1. Donohue J: Mental health in the Medicare Part D drug benefit: a new regulatory model? Health Affairs 25:707-719, 2006
2. Donohue JM, Huskamp HA, Zuvekas SH: Dual-eligibles with mental disorders and Medicare Part D: how are they faring? Health Affairs 28:746-759, 2009
3. Summer L, Hoadley J, Hargraves E, et al: Medicare Part D Data Spotlight: Low-Income Subsidy Plan Availability. Menlo Park, Calif, Henry J Kaiser Family Foundation, Nov 2008. Available at www.kff.org/medicare/upload/7836.pdf
4. Hoadley J, Summer L, Thompson J, et al: The Role of Beneficiary-Centered Assignment for Medicare Part D. Pub no 07-14 Washington, DC, Medicare Payment Advisory Commission, June 2007. Available at www.medpac.gov/documents/June07- Bene-centered-assignment-contractor.pdf
5. Neuman P, Strollo MK, Guterman S, et al: Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors. Health Affairs 26:w630-w643, 2007
6. Smith V, Gifford K, Kramer S, et al: The Transition of Dual Eligibles to Medicare Part D Prescription Drug Coverage: State Actions During Implementation. Washington, DC, Kaiser Family Foundation, Kaiser Commission on Medicaid and the Uninsured, Feb 2006. Available at www.kaiserfamilyfoundation.org/medicaid/ upload/7467.pdf
7. Department of Health and Human Services: Medicare program: Medicare Advantage and prescription drug programs, MIPPA drug formulary and protected classes policies. Federal Register 74:2881-2888, 2009
8. Medicare Prescription Drug Benefit Manual. Chapter 6. Baltimore, Centers for Medicare and Medicaid Services, July 2008. Available at www.cms.hhs.gov/ PrescriptionDrugCovContra/downloads/R2PDBv2.pdf
9. Huskamp HA, Stevenson DG, Donohue JM, et al: Coverage and prior authorization of psychotropic drugs under Medicare Part D. Psychiatric Services 58:308-310, 2007 (Pubitemid 46480045)
10. West JC, Wilk JE, Muszynski IL, et al: Medication access and continuity: the experiences of dual-eligible psychiatric patients during the first 4 months of the Medicare prescription drug benefit. American Journal of Psychiatry 164:789-796, 2007
11. D'Agostino RB Jr: Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statistics in Medicine 17:2265-2281, 1998
12. Imbens GM, Wooldridge JM: Recent developments in the econometrics of program evaluation. Journal of Economic Literature 47:5-86, 2009
13. Soumerai SB, Zhang F, Ross-Degnan D, et al: Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change. Health Affairs 27:w185-w195, 2008 (Pubitemid 351770278)
14. West JC, Wilk JE, Rae DS et al: Medicare prescription drug benefits: medication access and continuity among dual eligible psychiatric patients. Journal of Clinical Psychiatry, in press
15. West JC, Wilk JE, Rae DS, et al: Medicaid prescription drug policies and medication access and continuity: findings from ten states. Psychiatric Services 60:601-610, 2009
16. Drake RJ, Pickles A, Bentall RP, et al: The evolution of insight, paranoia, and depression during early schizophrenia. Psychological Medicine 34:285-292, 2004 (Pubitemid 38239636)
17. Opler LA, Caton CL, Shrout P, et al: Symptom profiles and homelessness in schizophrenia. Journal of Nervous and Mental Disease 182:174-178, 1994
18. Robinson D, Woerner MG, Alvir JM, et al: Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry 56:241-247, 1999 (Pubitemid 29125132)
19. Svarstad BL, Shireman TI, Sweeney JK: Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatric Services 52:805-811, 2001
20. Swanson JW, Swartz MS, Borm R, et al: Involuntary out-patient commitment and reduction of violent behavior in persons with severe mental illness. British Journal of Psychiatry 176:324-331, 2000 (Pubitemid 30204657)
21. Weiden PJ, Kozma C, Grogg A, et al: Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatric Services 55:886-891, 2004 (Pubitemid 39025215)
22. Essock SM, Covell NH, Davis SM, et al: Effectiveness of switching antipsychotic medications. American Journal of Psychiatry 163:2090-2095, 2006
23. Lehman AF, Steinwachs DM, Survey Co-Investigators of the PORT Project: Patterns of usual care for schizophrenia: initial results from the Schizophrenia Patient Outcomes Research Team (PORT) Client Survey. Schizophrenia Bulletin 24:11-20, 1998
24. Pingitore DP, Scheffler RM, Sentell T, et al: Comparison of psychiatrists and psychologists in clinical practice. Psychiatric Services 53:977-983, 2002 (Pubitemid 34816090)